Zsofia Digby
Chesterford Research Park, Little Chesterford
Saffron Walden, ENG CB101XL, United Kingdom
Saffron Walden, ENG CB101XL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Anti-Inflammatory Effects of Oral NLRP3 Inhibition With Ruvonoflast Among Individuals at Elevated Cardiovascular Risk.
Journal: Journal of the American College of Cardiology
Published: April 10, 2026
Ester Prodrug NLRP3 Inflammasome Inhibitor NT-0796 is Brain Active due to Activation by Local Expression of Carboxylesterase-1.
Journal: ACS chemical neuroscience
Published: January 26, 2026
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an in vivo tool compound for neuroinflammatory disorders.
Journal: RSC medicinal chemistry
Published: July 22, 2025
Anti-Neuroinflammatory and Anti-Inflammatory Effects of the NLRP3 Inhibitor NT-0796 in Subjects with Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 08, 2025
The NLRP3 inhibitor NT-0796 enhances and sustains GLP-1R agonist-mediated weight loss in a murine diet-induced obesity model.
Journal: Obesity (Silver Spring, Md.)
Published: February 03, 2025
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 08, 2023
The age of heterozygous telomerase mutant parents influences the adult phenotype of their offspring irrespective of genotype in zebrafish.
Journal: Wellcome open research
Published: August 30, 2017
A high-resolution mRNA expression time course of embryonic development in zebrafish.
Journal: eLife
Published: July 28, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026